1994
DOI: 10.1016/0014-5793(94)00388-2
|View full text |Cite
|
Sign up to set email alerts
|

Purification and characterization of an endogenous inhibitor specific to the Z‐Leu‐Leu‐Leu‐MCA degrading activity in proteasome and its identification as heat‐shock protein 90

Abstract: We previously identified a benzyloxycarbonyl(Z)-Leu-Leu-Leu-4-methylcoumaryl-7-amide (ZLLL-MCA) degrading activity in proteasome as a candidate for the regulator of neurite outgrowth. As its counterpart, we purified a protein from bovine brain that specifically inhibits the ZLLL-MCA degrading activity in proteasome. This protein is heat stable and has no effect on the other catalytic activities in proteasome, or on the activities of trypsin, chymotrypsin, or m-and p-calpains either. The molar ratio ofinhibitor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
29
0
2

Year Published

1998
1998
2008
2008

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 74 publications
(34 citation statements)
references
References 33 publications
(18 reference statements)
2
29
0
2
Order By: Relevance
“…However, it does not require the aggregates to be in the insoluble filamentous state but merely requires a structural transition to a form present on both filaments and soluble oligomers, a transition that correlates to emergence of the epitopes recognized by the FILA-1 antibody. The inhibitory mode is noncompetitive and thus resembles the inhibitory effect by HSP-90 (49). It likely represents a structure change by the binding of the aggregated AS to the exterior of the ␤5 subunit, responsible for the chymotrypsin-like activity, and relayed to its catalytic site on its interior surface of the proteasomal barrel.…”
Section: ␣-Synuclein Inhibits the 20 S Proteasomementioning
confidence: 93%
“…However, it does not require the aggregates to be in the insoluble filamentous state but merely requires a structural transition to a form present on both filaments and soluble oligomers, a transition that correlates to emergence of the epitopes recognized by the FILA-1 antibody. The inhibitory mode is noncompetitive and thus resembles the inhibitory effect by HSP-90 (49). It likely represents a structure change by the binding of the aggregated AS to the exterior of the ␤5 subunit, responsible for the chymotrypsin-like activity, and relayed to its catalytic site on its interior surface of the proteasomal barrel.…”
Section: ␣-Synuclein Inhibits the 20 S Proteasomementioning
confidence: 93%
“…It is possible that neurite outgrowth through lactacystin-mediated proteasome inhibition mimics a normal mechanism involved in cellular differentiation. A number of endogenous inhibitors of the proteasome have been discovered, some of which affect multiple activities, whereas others are more specific (32)(33)(34). Endogenous regulators of proteasome activities might influence cell physiology and fate.…”
Section: The Proteasome and Cell Fatementioning
confidence: 99%
“…Hsp90 also shows direct interaction with the proteasome and might possess regulatory roles, other than determination of the fate of unfolded proteins that cooperate with co-chaperones, PA28 and CHIP. 31,40 Initially, Hsp90 was considered to inhibit the 20S proteasome 51,52 and also to protect it from oxidative stress. 53 Proteomics analysis of proteasome-interacting proteins revealed physical interactions between Hsp70 and Hsp90 with the 26S proteasome.…”
Section: Molecular Chaperonesmentioning
confidence: 99%